(CFN) CareFusion Corporation Enters Agreement with Masimo
CareFusion Corp. (CFN) entered into a multi-year technology licensing agreement with Masimo Corp. (MASI) regarding the use of Masimo Rainbow SET Pulse CO-Oximetry technology in CareFusion infusion and...
View Article(MASI) Masimo Corporation Renews Deal with Advocate Health Care
Masimo Corporation (MASI) announced that one of its prominent customers, Advocate Health Care, has recently renewed its multi-year, system-wide contract for Masimo SET pulse oximetry technology....
View Article(MASI) Masimo Corporation Earns FDA New Product Approval
Masimo Corporation (MASI) recently received the U.S. Food and Drug Administration (FDA) approval for its new product, Masimo Rainbow SET Acoustic Monitoring. The new product enables noninvasive and...
View Article(MASI) Masimo Completes Conversion of New Customer
Masimo Corp. (MASI) reported that its new customer, Brookdale University Hospital and Medical Center in Brooklyn, New York, has completed its system-wide conversion to Masimo SET pulse oximetry...
View Article(MASI) Masimo Corporation in Expansion Mode
Masimo Corp. (MASI) recently announced the expansion of its corporate campus in Irvine, California with the addition of an adjacent 32,000 sq. ft. building. This is the company’s third building on its...
View Article(ZOLL) ZOLL Medical Corporation Earns FDA Clearance
Recently, ZOLL Medical Corporation (ZOLL) announced that the U.S. Food and Drug Administration (FDA) approved the marketing of its E series defibrillators equipped with carbon monoxide (CO) monitoring....
View Article(MASI) Masimo Corporation Can Now Earn While Patients Test Device Effectiveness
Masimo Corporation (MASI) has recently received a new Current Procedural Terminology (CPT) code from the American Medical Association, 88738, for its noninvasive hemoglobin (SpHb) measurement. Medicare...
View Article(MASI) Masimo Corporation Announces Positive Results From Clinical Study
Masimo Corporation (MASI) recently announced positive results form its 21-month clinical study on the impact of the Masimo Patient SafetyNet remote monitoring and clinician notification system. Results...
View Article(MASI) Masimo Analysts Maintain Neutral Rating
We continue to maintain our ‘Neutral’ rating on Masimo Corp. (MASI) with a target price of $28 based on a P/E of 28.0x our fiscal 2010 EPS estimate of $1. The company’s fourth quarter fiscal 2009...
View Article(MASI) Masimo Wins New Customer Nassau University Medical Center
Masimo Corp. (MASI) recently reported that its new customer, Nassau University Medical Center (NUMC), has completed its system-wide conversion to Masimo SET pulse oximetry technology. The conversion...
View Article(SNN) MedTech Industry Stock Outlook – October 2012 – Zacks Analyst Interviews
The global medical devices industry is fairly large, intensely competitive and highly innovative. A regulated industry, MedTech is spread across different segments including cardiology, cardiovascular,...
View Article(HSIC) Henry Schein Forays into Ireland
Henry Schein, Inc. (HSIC), a leading healthcare products and services distributor, has been on an acquisition spree over the recent past. The company has successfully maintained this best price cialis...
View Article(MASI) Another Client Win for Masimo
Masimo Corporation (MASI), a leader in non-invasive monitoring technology, recently announced that the University of North Carolina (UNC) Hospitals in Chapel Hill have adopted Masimo SET pulse...
View Article
